BlackRock’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
2,301,845
+538,075
| +31% | +$2.72M | ﹤0.01% | 3281 |
|
|
2025
Q1 | $9.97M | Buy |
1,763,770
+579,823
| +49% | +$3.28M | ﹤0.01% | 3289 |
|
|
2024
Q4 | $10.3M | Buy |
1,183,947
+58,268
| +5% | +$506K | ﹤0.01% | 3371 |
|
|
2024
Q3 | $7.8M | Buy |
1,125,679
+302,608
| +37% | +$2.1M | ﹤0.01% | 3487 |
|
|
2024
Q2 | $5.1M | Buy |
823,071
+775,491
| +1,630% | +$4.81M | ﹤0.01% | 3626 |
|
|
2024
Q1 | $75.2K | Sell |
47,580
-1,705
| -3% | -$2.69K | ﹤0.01% | 4735 |
|
|
2023
Q4 | $72.5K | Sell |
49,285
-564
| -1% | -$829 | ﹤0.01% | 4816 |
|
|
2023
Q3 | $45.9K | Sell |
49,849
-1,974
| -4% | -$1.82K | ﹤0.01% | 4953 |
|
|
2023
Q2 | $65.3K | Buy |
51,823
+5,279
| +11% | +$6.65K | ﹤0.01% | 4933 |
|
|
2023
Q1 | $62.8K | Buy |
46,544
+7,497
| +19% | +$10.1K | ﹤0.01% | 4989 |
|
|
2022
Q4 | $69.9K | Sell |
39,047
-85,923
| -69% | -$154K | ﹤0.01% | 5060 |
|
|
2022
Q3 | $393K | Sell |
124,970
-4,407
| -3% | -$13.9K | ﹤0.01% | 4706 |
|
|
2022
Q2 | $420K | Sell |
129,377
-2,945
| -2% | -$9.56K | ﹤0.01% | 4739 |
|
|
2022
Q1 | $674K | Buy |
132,322
+17,708
| +15% | +$90.2K | ﹤0.01% | 4703 |
|
|
2021
Q4 | $896K | Buy |
114,614
+92,288
| +413% | +$721K | ﹤0.01% | 4627 |
|
|
2021
Q3 | $242K | Buy |
+22,326
| New | +$242K | ﹤0.01% | 4875 |
|